PATENT CLAIM ANALYSIS

Application Number: 16438135
Application Type: Utility
Filing Date: 2019-06
Publication Date: 2019-10
Patent Classification: ["544", "281000"]

Abstract:
Compounds of Formula (00A) and methods of use as Janus kinase inhibitors are described herein.

Claim (Index 10):
The compound of  claim 1 , further defined as a compound of Formula (IX): wherein:\n R 0j  is H or NH 2 ; \n R 3j  is selected from the group consisting of H and C 1 -C 6  alkyl optionally substituted by OH, 3-6 membered cycloalkyl, \u2014O\u2014(C 1 -C 6  alkyl), \u2014O\u2014(C 1 -C 6  alkyl)-OH, \u2014SO 2 \u2014(C 1 -C 6  alkyl) and phenyl, wherein the phenyl is optionally substituted by CN; \n R 4j  is selected from the group consisting of H and C 1 -C 6  alkyl optionally substituted by OH; \n or R 3j  and R 4j  together form a 4-6-membered heterocycloalkyl; \n R 5j  is selected from the group consisting of H and C 1 -C 6  alkyl; and \n Ring K is a 6-7 membered heterocycloalkyl wherein p 1j  is 1 or 2 and p 2j  is 1 or 2.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 100.0
- Lexical Diversity: 1.05882
- Patent Class: 544.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15139164', '15543826', '14904801', '14451600', '15257926']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8094102485671152
- 35 USC 102 Novelty (BERT): 0.5845459123089889
- Combined Prediction Score: 0.7869238149413026
- Mean Citation Score: 405.063252
- Max Citation Score: 495.0762
- Similarity Product: 432.5839109099864

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test